Dipropylenglykolmonobutylether, min 98 %, zur Synthese, 2.5 l, kunststoffverpackung.

2-([1,1'-Biphenyl]-4-ylcarbamoyl)benzoic acid, 95.0%, 25mg

2-(dimethylamino)butanoic acid, 95.0%, 5g

Dibenzo[f,h]quinoxaline, 95.0%, 5g

n-Decan, min. 99 %, zur Synthese, 1 l, Glasverpackung

6-(Chloromethyl)-2-methylpyrimidin-4-ol, 95.0%, 1g

3-[(2-methylprop-2-enoyl)oxy]adamantan-1-yl 2-methylprop-2-enoate, 98%, 1g

Sodium-2-naphthol-7-sulfonate, 98.0%, 25g

2-Amino-3-formylpyridine, 98.0%, 5g

4,6-Dichloro-5-pyrimidinecarboxaldehyde, 97.0%, 1kg

trans-beta-Farnesene>95.0%(GC)1g

1-[(benzyloxy)carbonyl]-5,5-difluoropiperidine-3-carboxylic acid, 97.0%, 100mg

3-(BENZO[D]THIAZOL-2-YL)-6-ETHYL-7-HYDROXY-8-(PIPERIDIN-1-YLMETHYL)-4H-CHROMEN-4-ONE, 97%, 250mg